Ionizing radiation is a potent lung carcinogen, but the precise molecular damage associated with it is still unknown. In this study we investigated cancer-related molecular abnormalities including K-ras (codon 12) mutation, p16
Introduction
Lung cancer is the leading cause of cancer-related death in the industrial world, and nearly all lung cancer is environmentally induced (Landis et al., 1998) . Much evidence has been provided that invasive lung cancer is the end result of the stepwise accumulation of genetic alterations. As with other epithelial malignancies, lung cancer is thought to arise through a series of morphologic changes (preneoplastic lesions) that progress over a period of several years to decades (Saccomano et al., 1974) . However, genetic alterations that identify normal or preneoplastic bronchial tissue at risk for malignant progression are poorly understood.
Tobacco smoking is accepted as a major risk factor for lung cancer. A large number of both epidemiologic and molecular studies have revealed the positive link between cigarette smoking and risk of development of this neoplasm (Parkin et al., 1994; Mao et al., 1997; Wistuba et al., 1997) . Ionizing radiation is another well-established risk factor for a number of human malignancies. Many epidemiologic studies revealed association between both occupational and indoor exposure to radon and an enhanced risk for development of lung cancer (Little, 1997) . Despite the fact that ionizing radiation was the ®rst recognized mutagen (Muller, 1927) , the precise molecular lesions induced by ionizing radiation are still unknown.
Investigation of radiation exposure induced carcinogenesis has become especially important after the Chernobyl accident when massive levels of ®ssion products were released as a result of failure of the reactor unit (Anspaugh et al., 1988) . Thousands of men from all the former Soviet Union were sent to the Chernobyl area to entomb the damaged reactor and to decontaminate the environment. During their stay at the site they experienced protracted exposure to low doses of exogenous ionizing radiation and high concentration of radioactive particles due to environment contamination (Israel et al., 1987; Chuchalin et al., 1995) . The eect of such exposures on humans has been assessed only in a few epidemiological and theoretical studies . The health risk assessment has so far been uncertain due to lack of detailed and reliable information about the exposure.
Earlier, a link was shown between chronic respiratory problems in former Chernobyl clean-up workers (FChCW) and persistence of the inhaled radioactive particles in their lungs (Chuchalin et al., 1995) . In animal studies, simulated nuclear fuel particles can eciently induce benign and malignant tumors in the lungs of dierent experimental animals (Lundgren et al., 1982; Sanders et al., 1993; Pasanen et al., 1995) , suggesting an enhanced risk of lung cancer among individuals exposed to nuclear fuel particles. Taking into account this background we investigated cancerrelated molecular changes in successive bronchial biopsies of FChCW in comparison with control group of smokers (SM) and nonsmokers (NS) who have never had ionizing radiation exposure.
Results

Subjects characteristics
We investigated successive bronchial biopsies obtained from 43 FChCW (36 smokers and seven nonsmokers) in 1992 ± 2001, several years (6 ± 15) after their work at the Chernobyl site. At the time of their recruitment into the study, 41 (95.3%) of them had`Chernobyl dust' containing such elements as Sr, Zr, Ce, I, Cs, Np, Pu, Am and Cm in their bronchial alveolar lavage (BAL) samples. Average percentage of macrophages containing phagolysosomes with radioactive material found in their BAL was 32.3% and ranged from 1 to 55%. As a control we used samples of bronchial epithelium from 21 SM and 23 NS. Other subject relevant information is presented in Table 1 .
The distribution of histologic categories in biopsy specimens obtained from dierent groups of subjects is presented in Table 2 . Interestingly that frequency of dysplastic changes was signi®cantly higher in biopsy specimens obtained from nonsmoking FChCW than in those from NS (5 (21.7%) of 23 versus 0 (0%) of 69, P=0.0007). In addition, marginally signi®cant dierence was reached when frequency of dysplastic changes was compared in smoking FChCW and SM (25 (23.8%) of 105 versus 10 (14.5%) of 69, P=0.17). This dierence may become statistically signi®cant when more samples are studied in our ongoing clinical trial.
Molecular changes and pattern of carcinogen exposure
In this study we examined mutation in K-ras (codon 12), p16
INK4A promoter hypermethylation, and microsatellite alterations at seven chromosomal regions (3p12, 3p14.2 (FHIT), 3p21, 3p22-24 (hMLH1), 3p25, 9p21 (p16 INK4A ), 17p13 (TP53)). These markers have been previously shown to exhibit a high frequency of alteration in lung cancer (Sekido et al., 1998; Wistuba et al., 1999; SanchezCespedes et al., 2001) . Figure 1a ,b,c shows an example of representative case investigated.
Our results reveal a complete absence of molecular changes in each biopsy specimen obtained from NS. In contrast, at least one molecular abnormality was found in 26 (72.2%) of 36 FChCW with smoking history, in four (57.1%) of seven FChCW who had never smoked and in 12 (57.1%) of 21 SM (Table 3 ). In FChCW the number of molecular changes per subject (Fractional Molecular Alteration (FMA) index of the latest biopsy sample) was strongly associated with amount of radioactive dust found in their BAL samples (r=0.41, P=0.01) but not with exogenous radiation or smoking exposure (r=0.18, P40.05 and r=0.2, P40.05, respectively).
Both smoking FChCW and SM revealed entire spectrum of molecular alterations investigated in their bronchial epithelium (Table 3 ). The only signi®cant dierence between these two groups was frequency of allelic loss at 3p14.2 (FHIT) that was much more higher (P50.05) in smoking FChCW than in SM. Important that LOH at this region was also frequently detected in bronchial epithelium of nonsmoking FChCW. Allelic loss at 3p12 and 3p21 occurred in irradiated and non-irradiated smokers as well as in irradiated nonsmokers with the tendency of cumulative eect when both damaging factors were present. LOH at 3p22-24 (hMLH1) and 9p21 (p16
INK4A
) occurred similarly but with no cumulative eect. These data indicate that radiation exposure may be one of the causes of LOH at ®ve chromosomal regions mentioned above.
K-ras mutation, p16 INK4A promoter hypermethylation, LOH at 3p25 and 17p13 (TP53), and MI at any locus were detected only in biopsy specimens obtained from smokers (with or without radiation exposure) (Table 3 ). These data indicate that they may be associated exclusively with the exposure to tobacco smoking.
Comparison of molecular and histologic changes
In the total group of subjects with a history of carcinogen (radiation, tobacco smoke or both) exposure mean FMA-sample index increased from histologically normal bronchial epithelium (0.084+0.013, n=83) to hyperplasia/metaplasia (0.1+0.014, n=74) with signi®-cant rise (0.24+0.026, n=40, P=0.0001) occurred in dysplasia stage. On analysing molecular alterations of individual markers we found that LOH at 3p12, 3p21, 3p22-24 (hMLH1), and 9p21 (p16 INK4A ), and MI at any locus were the earliest events frequently detected in histologically normal biopsy specimens, whereas K-ras mutation, p16
INK4A promoter hypermethylation, and LOH at 3p14.2 (FHIT), 3p25 and 17p13 (TP53) loci demonstrated a strong association with the presence of dysplastic lesions ( Figure 2 , Table 4 ).
Appearance of molecular alterations and morphological changes in bronchial epithelium of FChCW during the follow-up
One of the major aims of the current study was to ®nd factors that determine progression of normal and premalignant epithelium to more advanced lesions. For this purpose we analysed repetitive biopsies taken (Table  1) . During the period of the follow-up 10 dysplasias appeared de novo. The clonal relationship between these dysplasias and histologically less advanced foci obtained earlier was con®rmed by comparison of pattern of their molecular alterations. When we analysed dysplasia precursor clones (hystologically normal or mildly abnormal clones that subsequently progressed to dysplasia), we found that their mean FMA index was signi®cantly higher than that calculated for normal or mildly abnormal epithelial foci without evidence of further progression (0.19+0.04, n=10 versus 0.06+0.01, n=88, P=0.002) and was nearly identical to mean FMA index found for dysplasia (0.24+0.04, n=30). However we could not isolate any single molecular alteration that would signi®cantly predict rapid progression of tobacco smoke and/or radioactivity exposed bronchial epithelium (data not shown). Thus, only the combination of a panel of molecular markers could provide approach for identi®cation of the epithelial foci that at high risk of progression to more advanced stages.
Comparison of FHIT mRNA expression with carcinogen exposure pattern and 3p14.2 LOH To understand biological meaning of allelic loss at 3p14.2 that were signi®cantly associated with the presence of inhaled radioactive dust we investigated expression of potential tumor suppressor gene FHIT located at this chromosomal region. The level of the FHIT transcripts was determined in brushings obtained from FChCW and SM (Table 1) by semi-quantitative RT ± PCR. Results from 12 representative specimens investigated are shown at Figure 3 . A fragment of the FHIT transcript was generated in 63 (87.5%) of 72 brushings investigated. Expression of the FHIT was signi®cantly lower in specimens obtained from FChCW than in those obtained from SM (0.6+0.07, n=43 versus 0.84+0.07, n=29, P=0.03) and in specimens with 3p14.2 LOH than in those retaining both copies of the gene (0.41+0.13, n=13 versus 0.77+0.05, n=49, P=0.02). Interestingly, all nine brushings with negative FHIT expression were obtained from FChCW. In addition, six (66.7%) of them demonstrated LOH at 3p14.2, whereas only seven (13.2%) of 53 informative samples with positive FHIT expression revealed the same alteration (P=0.001).
Discussion
Because ionizing radiation is suspected to be a potent lung carcinogen (Lundgren et al., 1982; Sanders et al., 1993; Pasanen et al., 1995; Lang et al., 1995) , we investigated cancer-related molecular alterations including K-ras mutation, p16
INK4A promoter hypermethylation, and microsatellite alterations at seven chromosomal regions in bronchial epithelium of FChCW in comparison with SM and NS. To our knowledge, this is the ®rst study designed to investigate the frequencies and timing of molecular alterations in this group. While NS consisted of 23 healthy volunteers or subjects being investigated because of occupational exposure to nonradioactive dust or asbestos, no molecular changes were found in any of their 69 biopsy specimens. In contrast, extensive molecular damage was detected in bronchial specimens obtained from subjects with a history of radiation or tobacco smoke exposure.
Interpretation of frequent cancer-related abnormalities found in FChCW on radiation exposure is potentially limited by the fact that 36 (83.7%) of 43 subjects comprising this group were lifetime smokers and only seven (16.3%) of them had no smoking history. However several lines of evidence indicate that substantial molecular damage found in FChCW can not be attributed to carcinogens of tobacco smoke alone: (1) existence of signi®cant correlation between the amount of inhaled radioactive particles persisting in the subjects' lungs and the number of molecular changes found; (2) smoking FChCW had signi®cantly higher frequency of LOH at 3p14.2 (FHIT) than SM; and (3) four (57.1%) of seven never smoking FChCW had LOH at one or more of the ®ve chromosomal loci (3p12, 3p14.2 (FHIT), 3p21, 3p22-24 (hMLH1) and 9p21 (p16 INK4A )) tested in the current study (Table 3) . Thus we can conclude that at least some allelic loss at In addition, biopsy specimens obtained from FChCW revealed signi®cantly lower expression of FHIT than those obtained from SM that was associated with increased frequency of LOH at the locus of its location (3p14.2) in this group of subjects. There are experimental evidences that FHIT can negatively regulate cell proliferation by causing cell cycle arrest in S phase (Ji et al., 1999) . Thus reduction of expression of this gene as a result of its allelic loss may be a critical step allowing clonal expansion of premalignant epithelial foci and may be a novel mechanism in radiation induced carcinogenesis.
On the other hand, FChCW with smoking history did not show elevated frequency of K-ras mutation, p16
INK4A promoter hypermethylation, LOH at 3p25 and 17p13 (TP53), or MI at any locus in comparison with SM. In addition, none of bronchial biopsy samples obtained from nonsmoking FChCW had such abnormalities. In agreement with previous studies (Slebos et al., 1991; Wistuba et al., 1997; Gealy et al., 1999; Kersting et al., 2000) these data suggest that molecular alterations mentioned above appeared in bronchial epithelium of FChCW as a result of cigarette smoke carcinogen action.
The development of lung cancer requires multiple mutations and the accumulation of them during the preneoplastic process is not random but usually follows a pattern (Wistuba et al., 1999) . Similarly, in cancerfree subjects with a history of radiation or tobacco smoke exposure allelic loss at 3p12, 3p21, 3p22-24 (hMLH1) and 9p21 (p16 INK4A ), and MI at any locus were early events frequently detected in histological normal or mildly abnormal bronchial epithelium. In contrast, mutation in K-ras, p16
INK4A promoter hypermethylation, and LOH at 3p14.2 (FHIT), 3p25 and 17p13 (TP53) were strongly associated with dysplastic lesions; therefore they were the most sensitive markers of dysplasia status. Not depending on the pattern of carcinogen exposure (radiation, tobacco smoke or both), there was signi®cant rise of mean value of FMA-sample index occurred at dysplasia stage whereas the dierence between histologically normal and mildly abnormal epithelium was modest and not signi®cant. This is consistent with the observation that hyperplasia of the bronchial epithelium and squamous metaplasia are reactive changes that can spontaneously regress after cessation of carcinogen exposure. Severe dysplasia frequently proceeds to squamous cell carcinoma of the lung and seldom spontaneously regresses after smoking cessation (Auerbach et al., 1961; Lam et al., 1999) . Important that normal and mildly abnormal epithelial foci that subsequently progressed to dysplasia had signi®cantly higher mean FMA index than those without evidence of such progression. This is in agreement with the results of a recent study demonstrated that frequency of alterations of the Rb phosphorilation pathway (p16 INK4A and cyclin D) increased with increasing severity of preneoplastic lesions and that it was higher in patients developed lung cancer than in subjects with no cancer progression (Brambilla et al., 1999) . Thus evaluating biopsy specimens for molecular damage may provide an eective method for assessing the risk of developing lung cancer in cancer-free subjects. Furthermore, because genetic damage precedes morphological changes, molecular assays are more favorable technique for evaluation of bronchial biopsy specimens than their cytological examination. However, long-term follow-up is required to de®ne the clinical signi®cance associated with each type of molecular alteration.
In conclusion the ®ndings presented in the current study indicate that extensive molecular changes that approximate lifetime risk for lung cancer sequentially occur in bronchial epithelium of FChCW. We believe that the results of the current work can be considered as a strong argument for cleaning the radioactive particles out of their lungs. A therapeutic program providing regular BAL that had been shown to be an eective tool in the removing of alveolar macrophages containing radioactive dust (Chuchalin et al., 1997) is in progress now.
Materials and methods
Study populations
BAL, successive bronchial biopsy specimens and brushings were collected from 43 FChCW (36 smokers and seven nonsmokers) who participated in clean-up activities at Chernobyl area in 1986 after the Chernobyl reactor explosion. Control group consisted of 21 SM and 23 NS. All subjects (males) were born in Russia and lived in the Moscow area. Informed consent was obtained from all study participants. The study was approved by Review Boards of both the Cancer Research Center of RAMS and the Institute of Pulmonology.
FChCW were selected for the study based on the following criteria: (1) worked with radioactive contaminated materials for at least 30 days; (2) did not use respirator; (3) had no evidence of other occupational risk factors before and after the work at the Chernobyl site; and (4) had no history of respiratory symptoms before the work at the Chernobyl site. Other relevant subject information is presented in Table 1 . 
Sample collection
All FChCW included into this study had ®rst bronchoscopic examination in 1992 ± 1996, several years (6 ± 10) after the Chernobyl catastrophe. First, BAL was performed as previously described (Chuchalin et al., 1997) . Then brush biopsies were taken from the areas showing visual mucosal alterations or from the mucosa of right lower lobe if no such alterations were found. Immediately following the brush biopsies, pinch forceps biopsies were performed from the same sites and then were repeated several (from 1 ± 5) times during a 5 ± 9 year follow-up. Multiple samples of bronchial epithelium were also obtained from the control group using the same protocol. In all cases, subjects' fresh blood was collected and lymphocytes were used as source for constitutional DNA.
BAL and biopsy specimens analyses and DNA extraction BAL cells, after appropriate ®xation, were analysed for dierent types of inclusion under the electron microscope ®tted with the link energy-dispersive X-ray spectrometer and by X-ray¯uorescent spectral analysis as previously described (Chuchalin et al., 1995 (Chuchalin et al., , 1997 . Biopsy specimens were ®xed in buered 10% formalin, embedded in paran and sliced into 4-mm thick sections. Four sections from each specimen were stained with hematoxylin-eosin and were examined by two experienced pathologists. Histopathologic changes were categorized as: (1) Normal respiratory epithelium; (2) Mildly abnormal epithelium (hyperplasia or simple squamous metaplasia) and (3) Dysplasia. Discrete areas of normal and abnormal bronchial epithelium were microdissected from adjacent nonstained sections and used for DNA extraction as previously described (Chizhikov et al., 2001) . DNA from peripheral blood lymphocytes was extracted using standard methods (Davis et al., 1986) . Homogenized pellets of brushings were used for DNA and RNA extraction with Trizol reagent (Life Technologies, Gaithersburg, MD, USA).
Molecular markers
Mutant-enriched PCR (EPCR) technique was used to screen all biopsy for mutation in codon 12 of K-ras (Kahn et al., 1991) . Samples that were found positive for K-ras mutation by using EPCR were subjected to RFLP-based conventional PCR analysis to verify presence of mutant K-ras allele (Jiang et al., 1989) .
Methylation-speci®c PCR was used to determine the methylation status of the CpG island of p16 INK4A . The modi®ed DNA was then ampli®ed by use of both methylatedand unmethylated-speci®c primers as described (Herman et al., 1996) .
Fourteen microsatellite markers located at seven chromosomal regions: 3p12 (D3S1274 and D3S1284), 3p14.2 (D3S1234 and D3S1300 at the FHIT gene), 3p21 (D3S966 and D3S1573), 3p22-24 (D3S1611 and D3S1298, located within and nearly hMLH1 gene, respectively), 3p25 (D3S1293 and D3S1597), 9p21 (D9S171 and D9S1748, located nearly p16 INK4A ) and 17p13 (TP53 dinucleotide and pentanucleotide repeats) were detected by PCR ampli®cation as described previously (Chizhikov et al., 2001) . Primer sequences were obtained from the Human Genome Database, with the exceptions of TP53 pentanucleotide (Cawkwell et al., 1994) and dinucleotide (Jones and Nakamura, 1992) repeats. LOH was scored by visual detection of complete absence of one allele. MI was detected by a shift in the mobility of one allele (Figure 1c) . We con®rmed that molecular alterations were not artifacts by re-dissection and re-analysis of majority of the samples revealed them.
Measurment of mRNA expression of the FHIT gene
One mg of total RNA was converted to cDNA by using random primers with Superscript II reverse transcriptase (Life Technologies) following the manufacturer's protocol. One tenth of the cDNA was used for each PCR ampli®cation. Primers 5'-ATGTCGTTCAGATTTGGCCAAC-3' and 5'-TCATAGATGCTGTCATTCCTGT-3', were used for detecting of FHIT transcripts. As a control, GAPDH primers 5'-ACCTGACCTGCCGTCTAGAA-3' and 5'-TCCACCACC-CTGTTGCTGTA-3' were used. PCR cycles number (35 and 25 for ampli®cation of FHIT and GAPDH, respectively) was experimentally determined in pilot studies to limit the reaction in the linear stage. PCR products were fractionated in 1 ± 2% agarose gels, and visualized by staining with ethidium bromide. The level of FHIT transcripts was quanti®ed by the ratio of the intensity of the target signal over the intensity of the GAPDH signal using Total Lab software (Nonlinear Dynamics Ltd., Newcastle upon Tyne, UK).
Data analysis
The molecular analyses were performed in a blinded manner with respect to subject categories and other clinical information. After completion of molecular studies, the data were merged with the clinical data for combined analysis. Because heterozygosity at the dierent loci varied between subjects, the number of chromosomal regions actually tested in subjects varied. For this reason evaluation of overall allelic loss in biopsy samples obtained from dierent subjects was possible only by using Fractional Regional Loss (FRL) sample index originally designed by Wistuba et al. (1997) . As we investigated not only allelic loss of chromosomal regions but also other molecular markers, we modi®ed FRL-sample index to a FMA-sample index to compare overall molecular changes between individual biopsy specimens.
FMA-sample index=total number of molecular alterations/ total number of molecular markers tested, for any one biopsy.
Statistical analysis was performed using the SPSS for Windows (SPSS Inc., Chicago, IL, USA). Fisher's exact test and Mann ± Whitney U-test were used to compare categorical and continuous variables (presented as mean+standard error of the mean), respectively. Spearman correlation coecients were calculated between the number of molecular changes and the percentage of alveolar macrophages containing radioactive dust persisting in the subjects' lungs, exogenous radiation, and smoking exposures, respectively. Probability values of P50.05 were regarded as statistically signi®cant.
